SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
27-Aug-24 2:46 PM View: | Maher Bill Director | H&Q Life Sciences Investors (HQL) | 23-Aug-24 | Private Purchase | 650 | $15.37 | $9,990.50 | 61% 1.06K to 1.72K | |
18-Jul-24 2:56 PM View: | Dimartino Rose Director | H&Q Life Sciences Investors (HQL) | 16-Jul-24 | Private Purchase | 1,000 | $15.53 | $15,530.00 | 100% 0 to 1.0K | |
27-Jun-24 11:22 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 26-Jun-24 | Private Purchase | 100 | $14.07 | $1,407.00 | < 1% 3.43M to 3.43M | |
25-Jun-24 5:36 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 24-Jun-24 | Private Purchase | 13,812 | $14.08 | $194,473.00 | < 1% 3.42M to 3.43M | |
14-Jun-24 1:59 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 13-Jun-24 | Purchase | 8,467 | $13.82 | $117,014.00 | < 1% 3.41M to 3.42M | |
14-Jun-24 1:59 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 12-Jun-24 | Private Purchase | 2,400 | $13.88 | $33,312.00 | < 1% 3.41M to 3.41M | |
11-Jun-24 5:03 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 11-Jun-24 | Purchase | 2,039 | $13.76 | $28,056.60 | < 1% 3.4M to 3.41M | |
11-Jun-24 5:03 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 10-Jun-24 | Private Purchase | 9,704 | $13.71 | $133,042.00 | < 1% 3.39M to 3.4M | |
10-Jun-24 8:45 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 07-Jun-24 | Purchase | 3,763 | $13.72 | $51,628.40 | < 1% 3.39M to 3.39M | |
10-Jun-24 8:45 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 06-Jun-24 | Private Purchase | 9,598 | $13.80 | $132,452.00 | < 1% 3.38M to 3.39M | |
05-Jun-24 5:09 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 05-Jun-24 | Purchase | 26,083 | $13.76 | $358,902.00 | < 1% 3.35M to 3.38M | |
05-Jun-24 5:09 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 04-Jun-24 | Private Purchase | 33,357 | $13.50 | $450,320.00 | 1% 3.32M to 3.35M | |
03-Jun-24 5:11 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 31-May-24 | Private Purchase | 21,369 | $13.29 | $283,994.00 | < 1% 3.3M to 3.32M | |
31-May-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 30-May-24 | Purchase | 669 | $13.05 | $8,730.45 | < 1% 3.3M to 3.3M | |
31-May-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 29-May-24 | Purchase | 38,033 | $13.09 | $497,852.00 | 1% 3.26M to 3.3M | |
31-May-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 28-May-24 | Private Purchase | 8,714 | $13.38 | $116,593.00 | < 1% 3.25M to 3.26M | |
23-May-24 10:00 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 23-May-24 | Private Purchase | 1,303 | $13.50 | $17,590.50 | < 1% 3.25M to 3.25M | |
17-May-24 12:34 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 15-May-24 | Private Purchase | 34,755 | $14.19 | $493,173.00 | 1% 3.22M to 3.25M | |
14-May-24 1:50 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 10-May-24 | Private Purchase | 57,862 | $13.86 | $801,967.00 | 2% 3.16M to 3.22M | |
10-May-24 10:31 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 09-May-24 | Purchase | 17,373 | $13.80 | $239,747.00 | < 1% 3.14M to 3.16M | |
10-May-24 10:31 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 08-May-24 | Private Purchase | 10,986 | $13.70 | $150,508.00 | < 1% 3.13M to 3.14M | |
07-May-24 5:07 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 07-May-24 | Purchase | 50,161 | $13.76 | $690,215.00 | 2% 3.08M to 3.13M | |
07-May-24 5:07 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 06-May-24 | Private Purchase | 10,713 | $13.62 | $145,911.00 | < 1% 3.07M to 3.08M | |
02-May-24 4:50 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 02-May-24 | Purchase | 26,274 | $13.46 | $353,648.00 | < 1% 3.04M to 3.07M | |
02-May-24 4:50 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 01-May-24 | Private Purchase | 252 | $13.02 | $3,281.04 | < 1% 3.04M to 3.04M | |
01-May-24 10:23 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 30-Apr-24 | Private Purchase | 16,573 | $13.13 | $217,603.00 | < 1% 3.03M to 3.04M | |
29-Apr-24 4:54 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 26-Apr-24 | Private Purchase | 120,304 | $13.00 | $1,563,950.00 | 4% 2.91M to 3.03M | |
26-Apr-24 11:40 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 25-Apr-24 | Purchase | 97,574 | $12.99 | $1,267,490.00 | 3% 2.81M to 2.91M | |
26-Apr-24 11:40 AM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 24-Apr-24 | Private Purchase | 20,529 | $13.12 | $269,340.00 | < 1% 2.79M to 2.81M | |
23-Apr-24 8:00 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 23-Apr-24 | Purchase | 48,203 | $13.15 | $633,869.00 | 2% 2.74M to 2.79M | |
23-Apr-24 8:00 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 22-Apr-24 | Private Purchase | 2,022 | $12.88 | $26,043.40 | < 1% 2.74M to 2.74M | |
22-Apr-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 19-Apr-24 | Purchase | 42,459 | $12.84 | $545,174.00 | 2% 2.69M to 2.74M | |
22-Apr-24 3:08 PM View: | Saba Capital Management, L.P. 10% Owner | H&Q Life Sciences Investors (HQL) | 18-Apr-24 | Private Purchase | 81,738 | $12.80 | $1,046,250.00 | 3% 2.61M to 2.69M | |
12-Apr-24 9:20 AM View: | Goetz Kathleen Director | H&Q Life Sciences Investors (HQL) | 09-Apr-24 | Private Purchase | 400 | $13.32 | $5,327.32 | 58% 0.69K to 1.08K | |
04-Jan-24 2:23 PM View: | Reit Todd Director | H&Q Life Sciences Investors (HQL) | 02-Jan-24 | Private Purchase | 1,000 | $13.80 | $13,798.00 | 100% 0 to 1.0K | |
02-Jan-24 4:34 PM View: | Maher Bill Director | H&Q Life Sciences Investors (HQL) | 28-Dec-23 | Private Purchase | 1,000 | $13.57 | $13,570.00 | 100% 0 to 1.0K | |
25-Sep-23 5:35 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 25-Sep-23 | Private Purchase | 10,096 | $12.39 | $125,116.00 | 5% 187.42K to 197.52K | |
20-Sep-23 6:40 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 20-Sep-23 | Private Purchase | 12,000 | $12.68 | $152,206.00 | 7% 175.42K to 187.42K | |
24-Mar-22 3:16 PM View: | Goetz Kathleen Director | H&Q Life Sciences Investors (HQL) | 23-Mar-22 | Private Purchase | 92 | $16.27 | $1,501.85 | 16% 0.59K to 0.69K | |
27-Jan-22 1:33 PM View: | Goetz Kathleen Director | H&Q Life Sciences Investors (HQL) | 26-Jan-22 | Market Purchase | 593 | $17.54 | $10,403.70 | 100% 0 to 0.59K | 6% |
12-Aug-21 11:40 AM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 11-Aug-21 | Market Purchase | 6,403 | $21.63 | $138,497.00 | 5% 140.09K to 146.49K | (< 1%) |
26-Oct-20 5:27 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 26-Oct-20 | Market Purchase | 6,175 | $17.52 | $108,204.00 | 5% 125.66K to 131.84K | 13% |
21-Oct-20 7:18 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 21-Oct-20 | Market Purchase | 5,950 | $17.75 | $105,606.00 | 5% 119.71K to 125.66K | 11% |
23-Sep-20 3:56 PM View: | Bailey Jeffrey Allen Director | H&Q Life Sciences Investors (HQL) | 22-Sep-20 | Market Purchase | 580 | $17.28 | $10,022.40 | 100% 0 to 0.58K | 15% |
22-May-20 11:05 AM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 21-May-20 | Market Purchase | 5,950 | $17.74 | $105,557.00 | 5% 108.87K to 114.82K | 7% |
17-Mar-20 6:25 PM View: | Omstead Daniel R President Director | H&Q Life Sciences Investors (HQL) | 17-Mar-20 | Market Purchase | 8,300 | $13.27 | $110,107.00 | 9% 97.51K to 105.81K | 43% |
29-Jan-18 10:07 AM View: | Kent Thomas M Director | H&Q Life Sciences Investors (HQL) | 25-Jan-18 | Market Purchase | 1,300 | $21.04 | $27,348.00 | 100% 0 to 1.3K | (19%) |
29-Jun-15 2:47 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 29-Jun-15 | Market Purchase | 1,000 | $28.17 | $28,170.00 | (14%) 6.99K to 5.99K | 44% |
01-Jul-14 5:13 PM View: | Reardon William S Director | H&Q Life Sciences Investors (HQL) | 30-Jun-14 | Market Purchase | 200 | $19.75 | $3,950.00 | 14% 1.41K to 1.61K | (14%) |
30-Jun-14 5:35 PM View: | Stebbins Lucinda H Director | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 1,000 | $19.75 | $19,750.00 | 17% 5.99K to 6.99K | (14%) |